To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1
Clinical trial NCT00100074 · UNKNOWN
Trial details
- NCT number
- NCT00100074
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.